Admission LDL-C and long-term mortality in patients with acute aortic dissection: a survival analysis in China

Xin Zeng1, Xuan Zhou2, Xue-Rui Tan3

  • 1Department of Geriatrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

Insights

Lowering serum low-density lipoprotein cholesterol (LDL-C) in acute aortic dissection (AAD) patients may increase long-term mortality risk. This study found lower admission LDL-C levels are linked to worse outcomes in AAD survivors.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Biochemistry

Background:

  • Blood lipid levels significantly impact cardiovascular disease prognosis.
  • Acute aortic dissection (AAD) is a critical condition requiring careful prognostic evaluation.
  • The relationship between serum low-density lipoprotein cholesterol (LDL-C) and long-term outcomes in AAD patients warrants investigation.

Purpose of the Study:

  • To investigate the association between admission serum LDL-C levels and long-term mortality in patients diagnosed with AAD.
  • To determine if lower LDL-C levels predict increased mortality risk in AAD.

Main Methods:

  • Retrospective analysis of 284 AAD patients from February 2016 to September 2019.
  • Patients were stratified into low-level (<2.755 mmol/L) and high-level (≥2.755 mmol/L) LDL-C groups based on ROC curve analysis.
  • Kaplan-Meier survival analysis and multivariate Cox regression were employed to assess long-term mortality.

Main Results:

  • The optimal cut-off for LDL-C was determined to be 2.755 mmol/L.
  • Patients in the lower LDL-C group (<2.755 mmol/L) exhibited significantly higher long-term mortality (P<0.001).
  • Multivariate analysis confirmed that LDL-C <2.755 mmol/L was an independent predictor of increased AAD mortality (HR=3.287, P=0.001). Cystatin C also emerged as a risk factor.

Conclusions:

  • Lower admission serum LDL-C levels are associated with an increased risk of long-term mortality in patients with AAD.
  • These findings suggest a potential paradox where lower LDL-C may indicate a poorer prognosis in AAD.
Abstract